Macrocyclizing DNA-Encoded Peptides via Visible-Light-Mediated Desulfurisation

Xuan wang,Qingyi Zhao,Hanqing Zhao ,Shijie Zhang,Weiwei Lu,Yujun Zhao,Xiaojie Lu

DOI: https://doi.org/10.26434/chemrxiv-2024-f03hn

2024-10-14

Abstract:DNA-encoded library technology (DELT) facilitates the generation of billions of DNA-tagged macrocycles containing noncanonical amino acids, synthesized through diverse cyclization strategies. The varied appended residues and ring conformations expand chemical space, enabling the identification of hit compounds with improved properties such as higher binding affinity, enhanced metabolic stability, and increased oral bioavailability. This study expands the on-DNA chemical toolkit by introducing a DNA-compatible C(sp3)-C(sp3) bond formation method via a visible-light-mediated desulfurative macrocyclization. This reaction proceeds efficiently under mild conditions, exhibiting broad substrate scope and good conversions. Notably, the reaction condition is com-patible with free amines, allowing for late-stage modifications and the preparation of covalent DNA-encoded macrocyclic libraries.

Chemistry

What problem does this paper attempt to address?

The paper attempts to address the problem of developing an efficient and mild visible light-mediated desulfurization reaction method in DNA-encoded library technology (DELT) for the synthesis of cyclic peptides containing saturated carbon-carbon bonds. Specifically, the study aims to:

1. **Develop new macrocyclization strategies**: Achieve DNA-compatible C(sp³)-C(sp³) bond formation through a visible light-mediated desulfurization reaction, thereby efficiently synthesizing cyclic peptides.
2. **Expand the chemical toolbox**: Introduce this method into DNA-encoded library technology to increase the chemical diversity of macrocyclic compounds and enhance their biological activity.
3. **Validate the method's effectiveness**: Construct reversible and covalent DNA-encoded macrocyclic libraries containing millions of members, and screen for compounds with inhibitory activity through protein binding experiments.

Through these efforts, the researchers hope to provide a more diverse chemical space for drug discovery, particularly targeting challenging protein-protein interactions (PPIs).